Initial public offering of Wilson Therapeutics AB AB (SE) on Nasdaq Stockholm – SEK 480 million

Carnegie acted as joint global co-ordinator and joint bookrunner in the initial public offering of Wilson Therapeutics on Nasdaq Stockholm. Wilson Therapeutics is a biopharmaceutical company, based in Stockholm, Sweden that develops novel therapies for patients with rare diseases.May 2016.